MPM Asset Management’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

MPM Asset Management’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-21,806	Closed	-$178K	–	13
2016 Q2	$178K	Hold	21,806	–	–	0.06%	11
2016 Q1	$135K	Hold	21,806	–	–	0.04%	13
2015 Q4	$183K	Hold	21,806	–	–	0.03%	13
2015 Q3	$84K	Hold	21,806	–	–	0.01%	15
2015 Q2	$194K	Buy	+21,806	New	+$187K	0.03%	14

Other funds holding CLCD

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

GPP

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

MPM Asset Management's CLCD Position: Q3 2016 in Review

MPM Asset Management sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q3 2016, closing a stake of 21,806 shares — an estimated $178K sold.

MPM Asset Management first reported a position in CLCD in Q2 2015 and held it in 5 quarters. The position peaked at $194K in Q2 2015. 56 funds tracked by Wall St. Rank hold CLCD as of Q3 2016.

MPM Asset Management reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q3 2016 after selling out during the quarter.
MPM Asset Management sold 21,806 CoLucid Pharmaceuticals, Inc. shares in Q3 2016, an estimated $178K.
MPM Asset Management first reported a position in CoLucid Pharmaceuticals, Inc. in Q2 2015 and held it in 5 quarters.
MPM Asset Management's CoLucid Pharmaceuticals, Inc. position peaked at $194K in Q2 2015.
56 funds tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q3 2016.

Based on MPM Asset Management's 13F filing for Q3 2016, filed 10 Nov 2016.